Halmos Balazs, Tan Eng-Huat, Soo Ross A, Cadranel, Jacques, Lee Min Ki, Foucher, Pascal, Hsia, Te- Chun, Hochmair, Maximilian, Griesinger Frank, Hida, Toyoaki, Kim Edward, Melosky Barbara, Marten Angela, Carcereny Enric.Updates Regarding Biomarker Testing for Non-Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable. Kim ES, Roy UB, Ersek JL, King J, Smith RA, Martin N, Martins R, Moore A, Silvestri GA, Jett J.Targeted Therapy for Mutation-Driven Metastatic Non-Small- Cell Lung Cancer: Considerations for ALK-Rearranged Tumors. Implementing Precision Medicine in Community-Based Oncology Programs: Three Models. Levit LA, Kim ES, McAneny BL, Nadauld LD, Levit K, Schenkel C, Schilsky RL.Pulmonary Carcinoma: A Surveillance, Epidemiology, and End Results (SEER) Analysis. Ersek JL, Symanowski JT, Han Y, Howard A, Dumas K, Ahrens W, Kim E, Kim ES.Palbociclib in Patients With Pancreatic and Biliary Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |